Final report of the 5-year clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in the treatment of single de novo coronary lesions in a first-in-human study

BACKGROUND: We aimed to report the 5-year outcomes of XINSORB bioresorbable sirolimus-eluting scaffolds in the treatment of single de novo coronary lesions in a first-in-human (FIM) study. This is the final report of the long-term clinical outcomes of the study. Recent studies have shown that biores...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yizhe, Yin, Jiasheng, Chen, Jiahui, Yao, Zhifeng, Qian, Juying, Shen, Li, Ge, Lei, Ge, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576036/
https://www.ncbi.nlm.nih.gov/pubmed/33241011
http://dx.doi.org/10.21037/atm-20-5668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576036/
https://www.ncbi.nlm.nih.gov/pubmed/33241011
http://dx.doi.org/10.21037/atm-20-5668

Ejemplares similares